These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 9140004)

  • 1. BNP: pathophysiological and potential therapeutic roles in acute congestive heart failure.
    Grantham JA; Borgeson DD; Burnett JC
    Am J Physiol; 1997 Apr; 272(4 Pt 2):R1077-83. PubMed ID: 9140004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological actions of brain natriuretic peptide in thoracic inferior vena caval constriction.
    Clavell AL; Stingo AJ; Aarhus LL; Burnett JC
    Am J Physiol; 1993 Dec; 265(6 Pt 2):R1416-22. PubMed ID: 8285286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Equimolar doses of atrial and brain natriuretic peptides and urodilatin have differential renal actions in overt experimental heart failure.
    Chen HH; Cataliotti A; Schirger JA; Martin FL; Burnett JC
    Am J Physiol Regul Integr Comp Physiol; 2005 May; 288(5):R1093-7. PubMed ID: 15627648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of digoxin on atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and cyclic 3', 5'-guanosine monophosphate (cGMP) in patients with chronic congestive heart failure].
    Kobusiak-Prokopowicz M; Swidnicka-Szuszkowska B; Mysiak A
    Pol Arch Med Wewn; 2001 Jun; 105(6):475-82. PubMed ID: 11865578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digitalis increases brain natriuretic peptide in patients with severe congestive heart failure.
    Tsutamoto T; Wada A; Maeda K; Hisanaga T; Fukai D; Maeda Y; Ohnishi M; Mabuchi N; Kinoshita M
    Am Heart J; 1997 Nov; 134(5 Pt 1):910-6. PubMed ID: 9398103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maximizing the natriuretic peptide system in experimental heart failure: subcutaneous brain natriuretic peptide and acute vasopeptidase inhibition.
    Chen HH; Lainchbury JG; Harty GJ; Burnett JC
    Circulation; 2002 Feb; 105(8):999-1003. PubMed ID: 11864932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divergent effects of ANP and BNP in acute heart failure: evidence for a putative BNP-selective receptor?
    Brunner-La Rocca HP; Woods RL; Kaye DM; Hastings J; Thomas CJ; Lambert E; Esler MD
    J Hypertens; 2002 Jun; 20(6):1195-201. PubMed ID: 12023691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal, endocrine, and hemodynamic interactions of atrial and brain natriuretic peptides in normal men.
    Florkowski CM; Richards AM; Espiner EA; Yandle TG; Frampton C
    Am J Physiol; 1994 Apr; 266(4 Pt 2):R1244-50. PubMed ID: 8184968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of atrial and brain natriuretic peptides at pathophysiological levels in normal men.
    Hunt PJ; Espiner EA; Richards AM; Yandle TG; Frampton C; Nicholls MG
    Am J Physiol; 1995 Dec; 269(6 Pt 2):R1397-403. PubMed ID: 8594942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal role of the endogenous natriuretic peptide system in acute congestive heart failure.
    Stevens TL; Rasmussen TE; Wei CM; Kinoshita M; Matsuda Y; Burnett JC
    J Card Fail; 1996 Jun; 2(2):119-25. PubMed ID: 8798113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of myocardial and renal natriuretic peptides during acute intravascular volume overload in dogs: functional cardiorenal responses to receptor antagonism.
    Borgeson DD; Stevens TL; Heublein DM; Matsuda Y; Burnett JC
    Clin Sci (Lond); 1998 Aug; 95(2):195-202. PubMed ID: 9680502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic actions of a new synthetic vasoactive and natriuretic peptide, dendroaspis natriuretic peptide, in experimental severe congestive heart failure.
    Lisy O; Lainchbury JG; Leskinen H; Burnett JC
    Hypertension; 2001 Apr; 37(4):1089-94. PubMed ID: 11304508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure.
    Yoshimura M; Yasue H; Okumura K; Ogawa H; Jougasaki M; Mukoyama M; Nakao K; Imura H
    Circulation; 1993 Feb; 87(2):464-9. PubMed ID: 8425293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of endogenous atrial natriuretic peptide in DOCA-salt hypertensive rats. Effects of a novel nonpeptide antagonist for atrial natriuretic peptide receptor.
    Hirata Y; Matsuoka H; Suzuki E; Hayakawa H; Sugimoto T; Matsuda Y; Morishita Y; Kangawa K; Minamino N; Matsuo H
    Circulation; 1993 Feb; 87(2):554-61. PubMed ID: 8381060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible regulation of renin release by ANP in dogs with heart failure.
    Kanamori T; Wada A; Tsutamoto T; Kinoshita M
    Am J Physiol; 1995 Jun; 268(6 Pt 2):H2281-7. PubMed ID: 7611478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
    Cataliotti A; Boerrigter G; Costello-Boerrigter LC; Schirger JA; Tsuruda T; Heublein DM; Chen HH; Malatino LS; Burnett JC
    Circulation; 2004 Apr; 109(13):1680-5. PubMed ID: 15023890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma concentrations of atrial and brain natriuretic peptides and cyclic guanosine monophosphate in response to dobutamine infusion in patients with surgically repaired tetralogy of fallot.
    Hayabuchi Y; Matsuoka S; Kuroda Y
    Pediatr Cardiol; 1999; 20(5):343-50. PubMed ID: 10441688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A functional role for endogenous atrial natriuretic peptide in a canine model of early left ventricular dysfunction.
    Stevens TL; Burnett JC; Kinoshita M; Matsuda Y; Redfield MM
    J Clin Invest; 1995 Mar; 95(3):1101-8. PubMed ID: 7883958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of natriuretic peptides and cyclic GMP in hemodialysis patients with coronary artery disease.
    Osajima A; Okazaki M; Kato H; Anai H; Tsuda Y; Segawa K; Tanaka H; Tamura M; Takasugi M; Nakashima Y
    Am J Nephrol; 2001; 21(2):112-9. PubMed ID: 11359018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natriuretic peptide analogues with distinct vasodilatory or renal activity: integrated effects in health and experimental heart failure.
    Rademaker MT; Scott NJA; Koh CY; Kini RM; Richards AM
    Cardiovasc Res; 2021 Jan; 117(2):508-519. PubMed ID: 32167565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.